| PERIOD ENDING | 26-Apr-09 | 25-Jan-09 | 26-Oct-08 | 27-Jul-08 | | Total Revenue | 1,020,077 | 1,333,396 | 2,043,677 | 1,848,168 | | Cost of Revenue | 864,558 | 941,820 | 1,244,972 | 1,105,854 | | | Gross Profit | 155,519 | 391,576 | 798,705 | 742,314 | | | Operating Expenses | | Research Development | 236,335 | 229,540 | 275,222 | 268,559 | | Selling General and Administrative | 185,758 | 225,356 | 238,541 | 245,285 | | Non Recurring | 26,709 | 132,772 | (31,523) | 138 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (293,283) | (196,092) | 316,465 | 228,332 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27,597 | (573) | 11,070 | 19,091 | | Earnings Before Interest And Taxes | (377,750) | (196,665) | 327,535 | 247,423 | | Interest Expense | 5,058 | 5,994 | 4,846 | 4,859 | | Income Before Tax | (382,808) | (202,659) | 322,689 | 242,564 | | Income Tax Expense | (127,418) | (69,725) | 91,594 | 77,796 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (255,390) | (132,934) | 231,095 | 164,768 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (255,390) | (132,934) | 231,095 | 164,768 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($255,390) | ($132,934) | $231,095 | $164,768 |
|
0.45% Nasdaq 
0.20%
Income Statement
